196 related articles for article (PubMed ID: 4943872)
1. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
Giuffrè R; Gambacorta D
Eur Neurol; 1971; 5(5):311-6. PubMed ID: 4943872
[No Abstract] [Full Text] [Related]
2. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
Matsumoto K; Omoto T; Beck H
Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
[No Abstract] [Full Text] [Related]
3. Amantadine for Parkinson's disease.
Mann DC; Pearce LA; Waterbury LD
Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
[No Abstract] [Full Text] [Related]
4. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
5. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
[No Abstract] [Full Text] [Related]
6. [Effects of 1-adamantil-amine chlorhydrate on parkinsonian asynkinesia].
Megna G
Acta Neurol (Napoli); 1971; 26(6):701-6. PubMed ID: 4946490
[No Abstract] [Full Text] [Related]
7. Interactions of L-dopa and amantadine in patients with Parkinsonism.
Cox B; Danta G; Schnieden H; Yuill GM
J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
[TBL] [Abstract][Full Text] [Related]
8. Stereotaxic intracerebral instillation of dopa.
Velasco Suárez MM; Escobedo FR
Confin Neurol; 1970; 32(2):149-57. PubMed ID: 4926179
[No Abstract] [Full Text] [Related]
9. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
[No Abstract] [Full Text] [Related]
10. [Clinical and electromyographic controls of the effect of dopamine in parkinsonian patients].
Tzavellas O; Umbach W
Arch Psychiatr Nervenkr (1970); 1967; 209(3):227-40. PubMed ID: 5340022
[No Abstract] [Full Text] [Related]
11. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
Campanella G; Carrieri P; Romito D; Pasqual-Marsettin E
Acta Neurol (Napoli); 1973; 28(1):1-34. PubMed ID: 4704396
[No Abstract] [Full Text] [Related]
12. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
Stellar S; Mandell S; Waltz JM; Cooper IS
J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909
[No Abstract] [Full Text] [Related]
13. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
Ambrosetto C; Martinelli P
Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
[No Abstract] [Full Text] [Related]
14. The management of Parkinson's syndrome.
Wanger SL
Med Clin North Am; 1972 May; 56(3):693-709. PubMed ID: 4556201
[No Abstract] [Full Text] [Related]
15. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
Bauer RB; McHenry JT
Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
[No Abstract] [Full Text] [Related]
16. L-dopa for parkinsonism.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
[No Abstract] [Full Text] [Related]
17. Amantadine versus L-2 dopa and amatadine plus L-dopa.
Fieschi C; Nardini M; Casacchia M; Tedone ME; Reitano M; Robotti E
Lancet; 1970 Jul; 2(7664):154-5. PubMed ID: 4194541
[No Abstract] [Full Text] [Related]
18. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
Giuffrè R; Gambacorta D
Minerva Med; 1971 Oct; 62(82):4009-12. PubMed ID: 5125066
[No Abstract] [Full Text] [Related]
19. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Danielczyk W; Korten JJ
Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
[No Abstract] [Full Text] [Related]
20. Combined L-dopa and amantadine in Parkinsonism.
Pollock M; Jorgensen PB
Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
